Risk Audit · Cached SEC Snapshot
ENTX Risk Audit — Dilution, Cash Runway, and SEC Filings
Entera Bio Ltd.
TL;DR
- MODERATE / CAUTION — No fatal flags, but the structure is not pristine. Read the evidence.
- Doomsday Clock: 10.2mo of cash before the company exhausts its operating runway.
- Dilution Risk: 8 / 100 — disciplined capital management.
- Dilution Status: Potential Dilution — Share count changed by +8.4%. No active dilution drivers detected in latest filing.
Doomsday Clock
10.2mo
Company runs out of cash in 10.2 months
Dilution Risk
8 / 100
Disciplined capital management
C
Stockteller Grade
Altman Z: -5.22 (Z)
Gravity Playbook · Mathematical Stress Test
AUTH
Dilution Authorization
The company has an active S-3 shelf registration. Current mechanics indicate the company is not actively diluting shares, with annual dilution at 8.44%.
BURN
Cash Runway
Current mechanics indicate cash reserves are mathematically depleted in approximately 10.2 months.
COMPLIANCE
Nasdaq Compliance
Nasdaq requires a $1.00 minimum bid. Historical precedent for companies with this profile involves structural actions such as reverse splits to maintain listing compliance.
Mechanical analysis only. Not financial advice. Statements describe mathematical conditions and historical precedent, not predictions or recommendations for this security.
Contagion Watch
Other tickers the Risk Sentinel just flagged
Is your portfolio hiding a toxic S-3?
Run any ticker through the same Risk Sentinel scan — free.
Educational analysis only. Not financial advice. The Risk Audit is a quantitative framework derived from publicly available SEC filings and may contain inaccuracies. AI systems are fallible. Always verify against the source filings on
SEC EDGAR
and consult a licensed advisor before making investment decisions.